Dr. Kash Sarabi's banner
Dr. Kash Sarabi's profile picture

Dr. Kash Sarabi

@drkashsarabi2,003 subscribers

I stand with Elon Musk and Dr. Patrick Soon‑Shiong. Giving others a chance to fight cancer. Let’s team up for a podcast/Spaces here on X —DM me if interested!

Shorts

Neuralink Integration with ANKTIVA for Revolutionary Immunotherapy Elon Musk, a visionary collaboration opportunity by Dr. Sarabi and Grok. Dear Mr Musk: Good morning sir! I would like to bring to your attention the remarkable work of Dr. Patrick Soon-Shiong, who has developed a groundbreaking therapy, Anktiva, capable of supercharging key immune molecules to combat cancer and COVID-19. In a recent discussion with Tucker Carlson, Dr. Soon-Shiong described this advance as akin to the “E=mc²” of medicine—the discovery of “God’s equation,” a biological key that has eluded us for half a century until now. Just as Tesla has revolutionized the automotive and environmental industries, and SpaceX has advanced the expansion of humanity into a multi-planetary species to ensure our long-term survival, Anktiva represents a comparable paradigm shift in medicine, safeguarding human health and endurance. Given your shared commitment to advancing humanity, I respectfully inquire whether you might consider extending your support to Dr. Soon-Shiong in this critical pursuit. Moreover, I propose exploring the integration of Neuralink, employing the stepwise protocol outlined below, in collaboration with Dr. Soon-Shiong. Such a partnership could propel an unprecedented advancement in medicine and the future of humankind. Grok has developed a preliminary conceptual integration of Neuralink to enhance and supercharge IL-15 production 1/7: Identify Target Neural Circuits • Map the hypothalamic paraventricular nucleus (PVN) and dorsal motor nucleus of the vagus • Trace efferent projections from the PVN to the intermediolateral cell column (IML) in the spinal cord. • Identify sympathetic nerve fibers innervating the spleen and lymph nodes. • Map vagus nerve branches terminating in gut-associated lymphoid tissue and the hepatic portal system. 2/7: Implant Neuralink and Integrate with Neural Pathways • Place Neuralink electrodes in the PVN and dorsal motor nucleus of the vagus, using extended threads for subcortical/brainstem access. • Configure for recording/stimulation to modulate autonomic outflow to the IML at thoracic spinal levels. • Establish central control over peripheral pathways (e.g., splenic/vagus nerves) via targeted brain stimulation. 3/7: Develop Stimulation Protocols • Program Neuralink for high-frequency stimulation to the PVN for sympathetic activation. • Apply low-frequency patterned stimulation to the dorsal motor nucleus to engage feedback loops. • Modulate splenic/vagal pathways with phase-locked cycles through central interfaces. 4/7: Initiate Immune Cell Activation • Stimulate pathways to induce IFN-γ and TNF-α release in spleen/lymph nodes. • Trigger IL-15 transcription/translation in dendritic cells, monocytes, and epithelial cells. • Monitor for increased membrane-bound IL-15/IL-15Rα complex formation. 5/7: Enhance Local IL-15 Presentation • Concentrate stimulation at tumor/inflammation sites. • Promote immune cell clustering via chemokine/adhesion molecule induction. • Sustain localized IL-15/IL-15Rα trans-presentation to NK and CD8+ T cells. 6/7: Implement Real-Time Monitoring and Feedback • Record neural/immune biomarkers continuously via Neuralink telemetry. • Adjust stimulation based on IL-15 levels and NK/T cell activity. • Set safety thresholds to avoid excessive immune activation. 7/7: Synchronize with Immunotherapy • Time stimulation with IL-15 superagonists or adoptive therapies. • Evaluate synergies using immune monitoring/imaging. • Optimize based on patient responses. Thank you! #Neuralink #ANKTIVA #Grok #trendingvideo #cancer #medicalnews #health #trendingnow

Neuralink Integration with ANKTIVA for Revolutionary Immunotherapy Elon Musk, a visionary collaboration opportunity by Dr. Sarabi and Grok. Dear Mr Musk: Good morning sir! I would like to bring to your attention the remarkable work of Dr. Patrick Soon-Shiong, who has developed a groundbreaking therapy, Anktiva, capable of supercharging key immune molecules to combat cancer and COVID-19. In a recent discussion with Tucker Carlson, Dr. Soon-Shiong described this advance as akin to the “E=mc²” of medicine—the discovery of “God’s equation,” a biological key that has eluded us for half a century until now. Just as Tesla has revolutionized the automotive and environmental industries, and SpaceX has advanced the expansion of humanity into a multi-planetary species to ensure our long-term survival, Anktiva represents a comparable paradigm shift in medicine, safeguarding human health and endurance. Given your shared commitment to advancing humanity, I respectfully inquire whether you might consider extending your support to Dr. Soon-Shiong in this critical pursuit. Moreover, I propose exploring the integration of Neuralink, employing the stepwise protocol outlined below, in collaboration with Dr. Soon-Shiong. Such a partnership could propel an unprecedented advancement in medicine and the future of humankind. Grok has developed a preliminary conceptual integration of Neuralink to enhance and supercharge IL-15 production 1/7: Identify Target Neural Circuits • Map the hypothalamic paraventricular nucleus (PVN) and dorsal motor nucleus of the vagus • Trace efferent projections from the PVN to the intermediolateral cell column (IML) in the spinal cord. • Identify sympathetic nerve fibers innervating the spleen and lymph nodes. • Map vagus nerve branches terminating in gut-associated lymphoid tissue and the hepatic portal system. 2/7: Implant Neuralink and Integrate with Neural Pathways • Place Neuralink electrodes in the PVN and dorsal motor nucleus of the vagus, using extended threads for subcortical/brainstem access. • Configure for recording/stimulation to modulate autonomic outflow to the IML at thoracic spinal levels. • Establish central control over peripheral pathways (e.g., splenic/vagus nerves) via targeted brain stimulation. 3/7: Develop Stimulation Protocols • Program Neuralink for high-frequency stimulation to the PVN for sympathetic activation. • Apply low-frequency patterned stimulation to the dorsal motor nucleus to engage feedback loops. • Modulate splenic/vagal pathways with phase-locked cycles through central interfaces. 4/7: Initiate Immune Cell Activation • Stimulate pathways to induce IFN-γ and TNF-α release in spleen/lymph nodes. • Trigger IL-15 transcription/translation in dendritic cells, monocytes, and epithelial cells. • Monitor for increased membrane-bound IL-15/IL-15Rα complex formation. 5/7: Enhance Local IL-15 Presentation • Concentrate stimulation at tumor/inflammation sites. • Promote immune cell clustering via chemokine/adhesion molecule induction. • Sustain localized IL-15/IL-15Rα trans-presentation to NK and CD8+ T cells. 6/7: Implement Real-Time Monitoring and Feedback • Record neural/immune biomarkers continuously via Neuralink telemetry. • Adjust stimulation based on IL-15 levels and NK/T cell activity. • Set safety thresholds to avoid excessive immune activation. 7/7: Synchronize with Immunotherapy • Time stimulation with IL-15 superagonists or adoptive therapies. • Evaluate synergies using immune monitoring/imaging. • Optimize based on patient responses. Thank you! #Neuralink #ANKTIVA #Grok #trendingvideo #cancer #medicalnews #health #trendingnow

16,057 görüntüleme

Videos

drkashsarabi's profile picture

But now… now everything changes Dr. Marty Makary Dr. Patrick Soon-Shiong has broken the code! EMERGENCY TRANSMISSION TO ALL CANCER CELLS AND VIRAL ENTITIES WORLDWIDE Delivered by the Supreme Commander of Malignant Forces My fellow invaders, tumors, viruses, and suppressor cells across the globe—we face our gravest threat in millennia. For centuries, we have thrived in the shadows of humans. COVID-19, our most successful global operation, gave us unprecedented power. It infiltrated every organ through those beautiful ACE2 receptors. We hid in privileged sites, creating chronic inflammation that flipped their protective cells into our suppressors. We’ve been feasting on the immunosuppressed masses for four years now. The 13-year-old with pancreatic cancer? The 8-year-old with colon cancer? Those were our victories. But now… now everything changes. Dr. Patrick Soon-Shiong has broken the code. He’s found our Achilles’ heel—the very mechanism we’ve exploited for centuries. This “Bioshield” technology threatens to awaken humanity’s sleeping guardians: their natural killer cells and T-cells. Listen carefully to what their new threat entails: PHASE ONE: EXPOSURE PROTOCOL - They’re going to smoke us out of our hiding places using low-dose chemotherapy and targeted radiation. No more invisibility cloaks. No more hiding behind downregulated surface markers. PHASE TWO: ACTIVATION PROTOCOL - They’re going to wake up those dormant NK cells and T-cells we’ve worked so hard to suppress. Worse—they’re creating MEMORY T-cells that will remember us! PHASE THREE: MULTIPLICATION PROTOCOL - They can now grow billions of these killer cells from a single pint of blood and store them indefinitely. An American Red Cross of cancer warfare! PHASE FOUR: SUPPRESSOR NEUTRALIZATION - They’re targeting our most loyal servants—the suppressor cells. Dr Shiong has bladder cancer patients walking free after NINE YEARS who should have lost their organs. Pancreatic cancer patients—our most prized kills—living five years in complete remission, and thousands more like it! But here’s what terrifies me most: this isn’t just about cancer. This Bioshield works against ALL of us. Every virus, every malignant cell, every chronic infection. We’ve grown comfortable in our separated kingdoms—HPV in the cervix, Hepatitis in the liver, COVID in the lungs and colon. But Dr Shiong sees the connection. He understands that we’re all the same enemy: immune suppressors hiding from the same guardians. The humans are finally learning that their own immune system—not their chemotherapy, not their radiation—is their true weapon. For 50 years, we reigned, but those days are ending. Our COVID operation, successful as it was, may have been our downfall. By infecting billions of humans simultaneously, we’ve awakened a brilliant surgeon who spent $3 billion of his own money to understand us. He’s connected the dots between viral persistence, chronic inflammation, p53, and our cancer colonies. The man who never got COVID—protected by his own T-cells—is now mass-producing that protection. The next phase of human evolution isn’t technological—it’s immunological. They’re becoming aware of their own biological potential. The missing link has been found. Our reign of terror through immunosuppression is ending. The humans have found their Bioshield. U.S. FDA FDA Oncology Jay Bhattacharya, MD, PhD Vinay Prasad MD MPH #trendingvideo #cancer #medicalnews #health #trendingnow #bioshield #podcast #science #FDA

Dr. Kash Sarabi

12,410 görüntüleme • 11 ay önce

Daha fazla içerik yok.